Green-mediated zinc oxide nanoparticles (ZnONPs) are being investigated for tissue engineering because of their potential biological activity and compatibility with biomaterial systems. However, evidence regarding their physicochemical characteristics, cytocompatibility, and tissue-specific regenerative effects remains heterogeneous. This systematic review aimed to synthesize the available evidence on plant-mediated ZnONPs, with particular emphasis on synthesis methods, nanoparticle characterization, biological responses, and potential applications in bone-related tissue engineering. A literature search was conducted across five electronic databases in accordance with PRISMA guidelines. Original studies reporting relevant information on green synthesis, physicochemical characterization, and quantitative biological outcomes were assessed for eligibility. Six studies were included in the current synthesis. The investigated plant sources included Cucurbita pepo, Artemisia annua, Scutellaria baicalensis, Epimedium brevicornum, Anethum graveolens, and sweet orange peel, alongside a study examining ZnO-containing polycaprolactone nanofibers for periodontal ligament stem cells. Reported nanoparticle characteristics varied across studies, reflecting differences in plant materials, precursor salts, synthesis conditions, and characterization techniques. Biological findings included concentration-dependent effects on cell viability, changes in osteogenic markers such as alkaline phosphatase, collagen type I, RUNX2, and osteocalcin, and increased matrix mineralization in selected experimental models. Antibacterial and antibiofilm activities were also reported in some studies. Nevertheless, incomplete methodological reporting and differences in biological assays limited direct comparisons between formulations. Overall, the findings indicate that plant-mediated ZnONPs warrant further investigation as potential components of bone-related biomaterials, but the available evidence is insufficient to establish their superiority over conventionally synthesized ZnONPs or confirm their clinical effectiveness. Future research should prioritize standardized synthesis and characterization protocols, comparable biological testing, systematic evaluation of dose-dependent cytotoxicity, and validation in appropriate in vivo models.